183 related articles for article (PubMed ID: 34966448)
1. Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma.
Dos Santos ML; França A; Lima Filho ACM; Florentino RM; Diniz PH; Oliveira Lemos F; Gonçalves CAX; Coelho VL; Lima CX; Foureaux G; Nathanson MH; Vidigal PVT; Leite MF
Oncol Lett; 2022 Jan; 23(1):32. PubMed ID: 34966448
[TBL] [Abstract][Full Text] [Related]
2. Expression of the type 3 InsP
Guerra MT; Florentino RM; Franca A; Lima Filho AC; Dos Santos ML; Fonseca RC; Lemos FO; Fonseca MC; Kruglov E; Mennone A; Njei B; Gibson J; Guan F; Cheng YC; Ananthanarayanan M; Gu J; Jiang J; Zhao H; Lima CX; Vidigal PT; Oliveira AG; Nathanson MH; Leite MF
Gut; 2019 Sep; 68(9):1676-1687. PubMed ID: 31315892
[TBL] [Abstract][Full Text] [Related]
3. Inositol 1,4,5-trisphosphate receptor type 3 plays a protective role in hepatocytes during hepatic ischemia-reperfusion injury.
Lima Filho ACM; França A; Florentino RM; Dos Santos ML; de Oliveira Lemos F; Missiaggia DG; Fonseca RC; Gustavo Oliveira A; Ananthanarayanan M; Guerra MT; de Castro Fonseca M; Vidigal PVT; Lima CX; Nathanson MH; Fatima Leite M
Cell Calcium; 2020 Nov; 91():102264. PubMed ID: 32957029
[TBL] [Abstract][Full Text] [Related]
4. Inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) is overexpressed in cholangiocarcinoma and its expression correlates with S100 calcium-binding protein A4 (S100A4).
Rodrigues MA; Gomes DA; Cosme AL; Sanches MD; Resende V; Cassali GD
Biomed Pharmacother; 2022 Jan; 145():112403. PubMed ID: 34798470
[TBL] [Abstract][Full Text] [Related]
5. Nuclear Factor, Erythroid 2-Like 2 Regulates Expression of Type 3 Inositol 1,4,5-Trisphosphate Receptor and Calcium Signaling in Cholangiocytes.
Weerachayaphorn J; Amaya MJ; Spirli C; Chansela P; Mitchell-Richards KA; Ananthanarayanan M; Nathanson MH
Gastroenterology; 2015 Jul; 149(1):211-222.e10. PubMed ID: 25796361
[TBL] [Abstract][Full Text] [Related]
6. Type 3 Inositol 1,4,5-Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma.
Ueasilamongkol P; Khamphaya T; Guerra MT; Rodrigues MA; Gomes DA; Kong Y; Wei W; Jain D; Trampert DC; Ananthanarayanan M; Banales JM; Roberts LR; Farshidfar F; Nathanson MH; Weerachayaphorn J
Hepatology; 2020 Feb; 71(2):583-599. PubMed ID: 31251815
[TBL] [Abstract][Full Text] [Related]
7. ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-ĸB/CD44 pathway in urinary bladder carcinoma.
Zhang M; Wang L; Yue Y; Zhang L; Liu T; Jing M; Liang X; Ma M; Xu S; Wang K; Wang X; Fan J
J Exp Clin Cancer Res; 2021 Feb; 40(1):65. PubMed ID: 33573671
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effects of inositol hexaphosphate on biomarker Itpr3 in induced colon rat carcinogenesis.
Guido M; Fagundes DJ; Ynouye CM; Pontes ER; Takita LC; Siufi do Amaral EG; Teruya R; Paes MC; Brasileiro JL; Aydos RD
Acta Cir Bras; 2008; 23(2):157-64. PubMed ID: 18372961
[TBL] [Abstract][Full Text] [Related]
9. Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonization.
Moy RH; Nguyen A; Loo JM; Yamaguchi N; Kajba CM; Santhanam B; Ostendorf BN; Wu YG; Tavazoie S; Tavazoie SF
Dev Cell; 2022 May; 57(9):1146-1159.e7. PubMed ID: 35487218
[TBL] [Abstract][Full Text] [Related]
10. Effects of Endotoxin on Type 3 Inositol 1,4,5-Trisphosphate Receptor in Human Cholangiocytes.
Franca A; Carlos Melo Lima Filho A; Guerra MT; Weerachayaphorn J; Loiola Dos Santos M; Njei B; Robert M; Xavier Lima C; Vieira Teixeira Vidigal P; Banales JM; Ananthanarayanam M; Leite MF; Nathanson MH
Hepatology; 2019 Feb; 69(2):817-830. PubMed ID: 30141207
[TBL] [Abstract][Full Text] [Related]
11. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
[TBL] [Abstract][Full Text] [Related]
12. Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival.
Alvarez M; Benhammou JN; Darci-Maher N; French SW; Han SB; Sinsheimer JS; Agopian VG; Pisegna JR; Pajukanta P
Genome Med; 2022 May; 14(1):50. PubMed ID: 35581624
[TBL] [Abstract][Full Text] [Related]
13. ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women.
Yang YC; Chang TY; Chen TC; Lin WS; Chang SC; Lee YJ
Oncotarget; 2017 Feb; 8(6):10085-10090. PubMed ID: 28036301
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of peri-apical targeting of inositol 1,4,5-trisphosphate receptor type 3 in cholangiocytes.
Rodrigues MA; Gomes DA; Fiorotto R; Guerra MT; Weerachayaphorn J; Bo T; Sessa WC; Strazzabosco M; Nathanson MH
Hepatol Commun; 2022 Oct; 6(10):2748-2764. PubMed ID: 35852334
[TBL] [Abstract][Full Text] [Related]
15. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
16. Type 3 inositol 1,4,5-trisphosphate receptor: A calcium channel for all seasons.
Mangla A; Guerra MT; Nathanson MH
Cell Calcium; 2020 Jan; 85():102132. PubMed ID: 31790953
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer.
Zheng W; Bai X; Zhou Y; Yu L; Ji D; Zheng Y; Meng N; Wang H; Huang Z; Chen W; Yam JWP; Xu Y; Cui Y
Aging (Albany NY); 2022 May; 14(10):4425-4444. PubMed ID: 35580861
[TBL] [Abstract][Full Text] [Related]
18. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.
Wahl K; Siegemund M; Lehner F; Vondran F; Nüssler A; Länger F; Krech T; Kontermann R; Manns MP; Schulze-Osthoff K; Pfizenmaier K; Bantel H
Hepatology; 2013 Feb; 57(2):625-36. PubMed ID: 22991197
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
